Average Co-Inventor Count = 2.91
ph-index = 17
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Neorx Corporation (44 from 156 patents)
2. Poniard Pharmaceuticals, Inc. (7 from 14 patents)
3. Other (2 from 832,912 patents)
4. University of Wa (1 from 2 patents)
53 patents:
1. 7744853 - Radiolabeled annexins
2. 7696331 - High dose radionuclide complexes for bone marrow treatment
3. 7691985 - Skeletal-targeted radiation to treat bone-associated pathologies
4. 7605239 - Skeletal-targeted radiation to treat bone-associated pathologies
5. 7408046 - Treatment of bone-associated cancers
6. 7385042 - Therapeutic and diagnostic compounds, compositions, and methods
7. 7378077 - High dose radionuclide complexes for bone marrow suppression
8. 7115720 - Therapeutic and diagnostic compounds, compositions, and methods
9. 7097823 - High dose radionuclide complexes for bone marrow suppression
10. 7094885 - Skeletal-targeted radiation to treat bone-associated pathologies
11. 7070759 - High dose radionuclide complexes for bone marrow suppression
12. 6767531 - High dose radionuclide complexes for bone marrow suppression
13. 6171577 - Radiolabeled annexins
14. 5976535 - Pretargeting protocols for the enhanced localization of cytotoxins to
15. 5968477 - Radiolabeled annexin conjugates with hexose and a chelator